August 2, 2025

Table S11 from RGN6024 Is a Brain-Penetrant, Small-Molecule Tubulin Destabilizer for the Treatment of Glioblastoma

View Full Paper

Ask AI

Bookmark

MAIN FINDING: RGN6024 effectively destabilizes tubulin, showing promise for glioblastoma treatment.
KEY EVIDENCE: Pharmacokinetic analysis indicates significant brain penetration and favorable plasma levels of RGN6024.
APPROACH: The study conducted animal trials with rats to evaluate pharmacokinetic parameters.
SIGNIFICANCE: This research highlights a potential new strategy in targeting glioblastoma through brain-penetrant small molecules.

No abstract yet

We only have this paper's title and publication details.

Pharmacokinetic data reveals RGN6024's brain penetration and efficacy in glioblastoma, suggesting a novel therapeutic pathway.

Plasma and brain pharmacokinetic parameters for RGN6024 in rats

No takes yet. Share an insight, caveat, or question.

Patrón et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Pharmacokinetic data reveals RGN6024's brain penetration and efficacy in glioblastoma, suggesting a novel therapeutic pathway.

Plasma and brain pharmacokinetic parameters for RGN6024 in rats